CIHR-ICR is thrilled to announce the official launch of the TRANSCAN-3 Joint Transnational Call (JTC) 2023: “Translational research on cancer epigenetics”. CIHR is partnering in this European Union-led initiative, which is comprised of 24 partners from 19 countries.
The objective of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers through the development of novel approaches based on a better understanding of cancer epigenetics. Researchers in Canada are strongly encouraged to apply.
Deadline for pre-proposals: July 21, 2023.
